Tevogen Bio Inc. (TVGN)

AI Score

Unlock

1.05

-0.03 (-2.78%)

At close: Apr 14, 2025, 3:59 PM

1.03

-1.90%

After-hours: Apr 14, 2025, 05:58 PM EDT

Tevogen Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	1.28M	2.33M	1.14M	1.32M	8.84K	347.55K	3.46M	52.28K	129.19K	143.05K	185.65K	231.55K	344.58K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10.97M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	16.68M	26.01M	25.68M	25.37M	356.86M	354.12M	352.38M	352.06M	351.92M	n/a
Other Long-Term Assets	575.84K	133.28K	133.28K	133.28K	-928.51K	-1.03M	-24.83M	n/a	-1.31M	n/a	n/a	38.95K	145.17K	166.79K
Receivables	158.82K	n/a	158.82K	158.82K	344.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	919.09K	1.2M	1.15M	923.2K	2.5K	0.00	0.00	44.78K	145.17K	275.43K	409.11K	502.61K	446.61K	n/a
Total Current Assets	2.36M	3.53M	2.45M	2.4M	355.84K	399.47K	3.67M	97.06K	274.36K	418.47K	594.75K	734.16K	791.19K	n/a
Property-Plant & Equipment	524.93K	628.48K	730.22K	830.21K	928.51K	1.03M	1.12M	n/a	1.31M	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.1M	761.75K	863.5K	963.49K	16.68M	26.01M	1.97M	25.37M	356.86M	354.12M	352.38M	352.1M	352.06M	166.79K
Total Assets	3.46M	4.29M	3.31M	3.36M	17.04M	26.41M	5.64M	25.47M	357.14M	354.54M	352.98M	352.83M	352.85M	166.79K
Account Payables	5.2M	5.84M	6.67M	5.21M	1.14M	1.89M	1.11M	n/a	210.45K	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	-250K	n/a	1.59M	n/a	-1.89M	340.38K	n/a	-375.81K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.88M	2.66M	1.92M	1.65M	1.63M	625.69K	62.93M	n/a	n/a	n/a	n/a	n/a	n/a	81.53K
Other Current Liabilities	1.96M	61.31K	369.93K	477.25K	-252.71K	-2.74M	251.52K	667.07K	-856.98K	281.78K	259.23K	179K	59.38K	71.67K
Total Current Liabilities	9.04M	10.42M	10.61M	8.94M	3M	1.83M	64.92M	667.07K	350.45K	281.78K	259.23K	179K	59.38K	153.2K
Long-Term Debt	5.8K	n/a	n/a	n/a	14.45M	29.21M	27.3M	n/a	39.3M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.08M	21.64K	235.4K	60.97K	39.28K	-14.73M	n/a	14.76M	-25.02M	14.79M	14.87M	15M	15.12M	n/a
Total Long-Term Liabilities	1.09M	64.2K	332.21K	227.76K	14.73M	14.74M	27.61M	14.76M	14.71M	14.79M	14.87M	15M	15.12M	n/a
Total Liabilities	10.14M	10.48M	10.94M	9.17M	17.73M	16.56M	92.53M	15.43M	15.06M	15.08M	15.13M	15.18M	15.18M	153.2K
Total Debt	1.89M	2.96M	2.02M	2.08M	1.63M	625.69K	90.83M	n/a	40.01M	n/a	n/a	n/a	n/a	81.53K
Common Stock	17.8K	17.08K	16.88K	16.46K	16.68M	26.01M	61.88K	25.37M	356.87M	354.13M	351.9M	351.9M	351.9M	1.2K
Retained Earnings	-113.39M	-103.94M	-98.06M	-88.39M	-17.38M	-16.16M	-92.12M	-15.33M	-14.78M	-14.66M	-14.05M	-14.26M	-14.23M	-11.41K
Comprehensive Income	n/a	n/a	n/a	-0.00	-0.00	-0.00	n/a	-33.95M	-0.00	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-6.67M	-6.19M	-7.63M	-5.8M	-695.8K	9.85M	-86.89M	10.05M	342.08M	339.47M	337.85M	337.65M	337.67M	13.59K
Total Investments	n/a	n/a	n/a	n/a	16.68M	26.01M	25.68M	25.37M	356.86M	354.12M	352.38M	352.06M	351.92M	n/a